It seems that Congress acting was key to actually seeing a reduction in insulin prices that had not occurred in a generation.
Ed Markey
The Public Record
Edward John Markey is a United States Senator from Massachusetts, having served since July 24, 2013. A member of the Democratic Party, Markey previously represented Massachusetts in the U.S. House of Representatives from April 14, 1976, to July 24, 2013. Throughout his career, he has been a strong advocate for environmental issues, telecommunications, and technology policy. Markey played a significant role in the development of legislation aimed at addressing climate change and promoting renewable energy sources.
Innovation without access is a hallucination for patients across the country.
There's nothing ultimately more important than democratization of access to opportunity through broadband access.
That's where the E-Rate came from and so far it's been $60 billion to make sure that kids get connected.
Yes, the Internet has to remain a free and open space for exchange of ideas.
The pandemic helped to expose the holes in the fabric of our digital infrastructure.
Students with access to laptops and high-speed Internet at home score higher on tests than their classmates without those resources.
I think it's a terrifying possibility, both in the short term and in the long term, in terms of the harm to children's learning if this fund expires.
Yes. And again we know we have a crisis in the country. One in three teenage girls contemplated suicide last year.
Will you continue to work with me to ensure that Next Era is properly managing alkali silica reaction at Seabrook?
So we just need to make sure that if we want to continue to have these plants get older and older and older, that we also build in the safeguards.
Now the price cuts that did occur followed intense public pressure and drug price reform in the Inflation Reduction Act.
That is just another reason why Congress should act to put together some formula that ensures that the benefits flow down to those most in need.
The first step we need to talk about is how to remove that [blockade on Medicare access for Alzheimer's drugs].
Innovation without access is a hallucination for patients across the country.
For those--for that cohort, people over 65 people, with preexisting conditions, immunocompromised, they still have to act as though the pandemic is still going on, in terms of protecting themselves.
Yes, I think that is a very important signal because it is a tale of two pandemics.





